Report Detail
Global Interventional X-ray Contrast and Imaging Agents Market Growth 2019-2024
- RnM3462429 |
- 27 May, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Other
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
According to this study, over the next five years the Interventional X-ray Contrast and Imaging Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional X-ray Contrast and Imaging Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional X-ray Contrast and Imaging Agents market by product type, application, key manufacturers and key regions and countries.
This study considers the Interventional X-ray Contrast and Imaging Agents value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Heart Disease
Neurological
Urology
General Surgery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interventional X-ray Contrast and Imaging Agents consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Interventional X-ray Contrast and Imaging Agents market by identifying its various subsegments.
Focuses on the key global Interventional X-ray Contrast and Imaging Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interventional X-ray Contrast and Imaging Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interventional X-ray Contrast and Imaging Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Interventional X-ray Contrast and Imaging Agents Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Interventional X-ray Contrast and Imaging Agents Consumption 2014-2024
- 2.1.2 Interventional X-ray Contrast and Imaging Agents Consumption CAGR by Region
- 2.2 Interventional X-ray Contrast and Imaging Agents Segment by Type
- 2.2.1 Iodinated Contrast Media
- 2.2.2 Barium-Based Contrast Media
- 2.2.3 Microbubble Contrast Media
- 2.2.4 Other
- 2.3 Interventional X-ray Contrast and Imaging Agents Consumption by Type
- 2.3.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Interventional X-ray Contrast and Imaging Agents Sale Price by Type (2014-2019)
- 2.4 Interventional X-ray Contrast and Imaging Agents Segment by Application
- 2.4.1 Heart Disease
- 2.4.2 Neurological
- 2.4.3 Urology
- 2.4.4 General Surgery
- 2.4.5 Other
- 2.5 Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 2.5.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Interventional X-ray Contrast and Imaging Agents Value and Market Share by Application (2014-2019)
- 2.5.3 Global Interventional X-ray Contrast and Imaging Agents Sale Price by Application (2014-2019)
3 Global Interventional X-ray Contrast and Imaging Agents by Manufacturers
- 3.1 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers
- 3.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2017-2019)
- 3.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers (2017-2019)
- 3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers
- 3.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2017-2019)
- 3.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers (2017-2019)
- 3.3 Global Interventional X-ray Contrast and Imaging Agents Sale Price by Manufacturers
- 3.4 Global Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
- 3.4.1 Global Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution and Sales Area by Manufacturers
- 3.4.2 Players Interventional X-ray Contrast and Imaging Agents Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Interventional X-ray Contrast and Imaging Agents by Regions
- 4.1 Interventional X-ray Contrast and Imaging Agents by Regions
- 4.1.1 Global Interventional X-ray Contrast and Imaging Agents Consumption by Regions
- 4.1.2 Global Interventional X-ray Contrast and Imaging Agents Value by Regions
- 4.2 Americas Interventional X-ray Contrast and Imaging Agents Consumption Growth
- 4.3 APAC Interventional X-ray Contrast and Imaging Agents Consumption Growth
- 4.4 Europe Interventional X-ray Contrast and Imaging Agents Consumption Growth
- 4.5 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption Growth
5 Americas
- 5.1 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Countries
- 5.1.1 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
- 5.1.2 Americas Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
- 5.2 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Type
- 5.3 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Countries
- 6.1.1 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
- 6.1.2 APAC Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
- 6.2 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Type
- 6.3 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Interventional X-ray Contrast and Imaging Agents by Countries
- 7.1.1 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
- 7.1.2 Europe Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
- 7.2 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Type
- 7.3 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Interventional X-ray Contrast and Imaging Agents by Countries
- 8.1.1 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
- 8.2 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption by Type
- 8.3 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Interventional X-ray Contrast and Imaging Agents Distributors
- 10.3 Interventional X-ray Contrast and Imaging Agents Customer
11 Global Interventional X-ray Contrast and Imaging Agents Market Forecast
- 11.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2019-2024)
- 11.2 Global Interventional X-ray Contrast and Imaging Agents Forecast by Regions
- 11.2.1 Global Interventional X-ray Contrast and Imaging Agents Forecast by Regions (2019-2024)
- 11.2.2 Global Interventional X-ray Contrast and Imaging Agents Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Interventional X-ray Contrast and Imaging Agents Forecast by Type
- 11.8 Global Interventional X-ray Contrast and Imaging Agents Forecast by Application
12 Key Players Analysis
- 12.1 Bracco
- 12.1.1 Company Details
- 12.1.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Bracco News
- 12.2 General Electric
- 12.2.1 Company Details
- 12.2.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 General Electric News
- 12.3 Guerbet
- 12.3.1 Company Details
- 12.3.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Guerbet News
- 12.4 Fujifilm Visualsonics
- 12.4.1 Company Details
- 12.4.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Fujifilm Visualsonics News
- 12.5 Imax
- 12.5.1 Company Details
- 12.5.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Imax News
- 12.6 J.B. Chemicals & Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 J.B. Chemicals & Pharmaceuticals News
- 12.7 Jodas Expoim
- 12.7.1 Company Details
- 12.7.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Jodas Expoim News
- 12.8 Lantheus Medical Imaging
- 12.8.1 Company Details
- 12.8.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Lantheus Medical Imaging News
- 12.9 Nano Therapeutics
- 12.9.1 Company Details
- 12.9.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Nano Therapeutics News
- 12.10 Novalek Pharmaceuticals
- 12.10.1 Company Details
- 12.10.2 Interventional X-ray Contrast and Imaging Agents Product Offered
- 12.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Novalek Pharmaceuticals News
- 12.11 Taejoon Pharm
- 12.12 Unijules Life Sciences
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Interventional X-ray Contrast and Imaging Agents . Industry analysis & Market Report on Interventional X-ray Contrast and Imaging Agents is a syndicated market report, published as Global Interventional X-ray Contrast and Imaging Agents Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Interventional X-ray Contrast and Imaging Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
